In December 2023, cancer specialists from China and the US came together to attend the virtual 3rd China-US Anti-Cancer Summit, co-organised by the China Anti-Cancer Association (CACA) and the US-China Anti-Cancer Association (USCACA).

 

Anti-cancer leaders from China and the US took part in presentations and a panel discussion and exchanged ideas and perspectives on the following:

  • The development of holistic, integrative management of cancer in China
  • Cancer research progress in the US
  • Innovations in oncology: the role of ASCO in improving cancer care
  • Treatment of advanced lung cancer: current and future perspectives

 

The panel of experts also discussed how to collaborate internationally to ensure global relevance of locally generated trial data and to harmonise regulations for trial endpoints to strengthen the global fight against cancer.

 

Educational objectives

 

  • Share insights and perspectives on the management and treatment of cancer patients in the US and China
  • Inform oncologists about the current and future developments in lung cancer 
  • Generate awareness of the latest innovations and progress in cancer research in the US and China

Programme summary
  • clock Duration 150 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from BeiGene Europe, AmoyDx and Fosun Pharma.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from BeiGene Europe, AmoyDx and Fosun Pharma.
Endorsement
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

animated-video Animated Video
Oncology 
Managing ADC toxicities in HER2+ metastatic breast cancer

Spotlight on nausea and vomiting

Experts
Dr Sara Tolaney
Endorsed by
ICAN international cancer advocacy network
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Aug 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca.
Oncology 
The latest developments in BRAF-mutant and MSI-H mCRC

Expert insights on recent clinical and real-world data

Experts
Prof. Chiara Cremolini
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jul 2025

This content is intended for HCPs outside the UK & ROI only. The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. This programme is supported by an Independent Educational Grant from Pierre Fabre Laboratories.  The programme is, therefore, independent; the content is not influenced by Pierre Fabre Laboratories and is under the sole responsibility of the experts. 
publication Scientific Publication
Oncology 
LEAP-012 publication

Expert insights on multimodal treatment for intermediate HCC

Experts
Prof. Arndt Vogel
Endorsed by
DiCE Global Liver Institute Blue Faery
ELPA
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2025

This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this programme.
Oncology Hemato-oncology 
Innovating relapsed refractory multiple myeloma care

Unmet needs, therapy management, and real-world experience

Experts
Assoc. Prof. María Victoria Mateos, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Elena Zamagni
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
ipcv Interactive Patient Case Video (IPCV)
Oncology 
NTRK fusion testing and treatment in pediatric sarcoma

Make decisions for a young patient during his cancer journey

Experts
Dr Theodore Laetsch
Endorsed by
NTRKers
  • clock MIN
  • calendar Jun 2025

Educational programme supported by an Independent Educational Grant from Bayer.
micro-learning Micro learning - Video, slides and more

Module

4

of 4

module
Oncology 
Navigating advanced HCC: treatment strategies beyond immunotherapy (IO)

Module 4: Treatment strategies for patients ineligible for IO or those with progression on IO 

Experts
Assoc. Prof. Lorenza Rimassa, Dr Amit Singal
Endorsed by
DiCE ELPA Global Liver Institute
Blue Faery AASLD
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2025

Educational programme supported by an Independent Educational Grant from Bayer.